Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for idiopathic steroid-sensitive nephrotic syndrome with secondary steroid resistance has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for idiopathic steroid-sensitive nephrotic syndrome with secondary steroid resistance.
11 publications have been identified in PubMed for idiopathic steroid-sensitive nephrotic syndrome with secondary steroid resistance. Research spans Review / Meta-Analysis (27%), Diagnostic / Biomarker (18%), and Case Report / Case Series (18%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 3 | 27% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 4:38 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Testing and diagnosis research |
2 |
18% |
Patient case studies | 2 | 18% |
Disease patterns and progression | 2 | 18% |
Clinical study results | 1 | 9% |
Laboratory research | 1 | 9% |
Chaudhary AK (2026). [PMID: 41259273](https://pubmed.ncbi.nlm.nih.gov/41259273/). *Jornal brasileiro de nefrologia*. [Diagnostic / Biomarker]
Kamigaki Y (2026). [PMID: 41735917](https://pubmed.ncbi.nlm.nih.gov/41735917/). *BMC nephrology*. [Basic Science / Preclinical]
Wang CS (2026). [PMID: 41577383](https://pubmed.ncbi.nlm.nih.gov/41577383/). *American journal of kidney diseases : the official journal of the National Kidney Foundation*. [Review / Meta-Analysis]
Guaragna MS (2025). [PMID: 39883133](https://pubmed.ncbi.nlm.nih.gov/39883133/). *Pediatric nephrology (Berlin, Germany)*. [Review / Meta-Analysis]
Sadat Sharif A (2025). [PMID: 39871511](https://pubmed.ncbi.nlm.nih.gov/39871511/). *Immunity, inflammation and disease*. [Diagnostic / Biomarker]
Kitahara M (2025). [PMID: 40297738](https://pubmed.ncbi.nlm.nih.gov/40297738/). *Biomedicine hub*. [Case Report / Case Series]
Mohanty N (2025). [PMID: 39902002](https://pubmed.ncbi.nlm.nih.gov/39902002/). *Cureus*. [Clinical Trial Publication]
Ermian B (2025). [PMID: 39910071](https://pubmed.ncbi.nlm.nih.gov/39910071/). *Scientific reports*. [Epidemiology / Natural History]
Badeńska M (2024). [PMID: 38674071](https://pubmed.ncbi.nlm.nih.gov/38674071/). *International journal of molecular sciences*. [Case Report / Case Series]
Yu N (2024). [PMID: 38383285](https://pubmed.ncbi.nlm.nih.gov/38383285/). *Renal failure*. [Epidemiology / Natural History]